Observation of the Therapeutic Effect of Compound Glycyrrhizin Injection on Chronic Hepatitis B
Yan Ning
Abstract
Yan Ning
Abstract
OBJECTIVE:To observe the therapeutic effect of compound glycyrrhizin injection(CG)on chronic hepatitis B(CHB).METHODS:45 patients with CHB were randomly divided into trial group(21 cases)and control group(22 cases)who received CG and diammonium glycyrrhizinate injection(DG)respectively.The changes of clinical symptoms,signs,liver function parameters and adverse reactions were observed after 12-week treatment.RESULTS:There were no significant differences in improvements of total bilirubin,ALT and AST between 2 groups(P0.05),however,adverse reactions in trial group were obviously less than those in control group.CONCLUSION:CG is effecacious and safe in the treatment of CHB and other damage of liver and its clinical efficacy is better than that of DG.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the therapeutic effect of compound glycyrrhizin injection(CG)on chronic hepatitis B(CHB).METHODS:45 patients with CHB were randomly divided into trial group(21 cases)and control group(22 cases)who received CG and diammonium glycyrrhizinate injection(DG)respectively.The changes of clinical symptoms,signs,liver function parameters and adverse reactions were observed after 12-week treatment.RESULTS:There were no significant differences in improvements of total bilirubin,ALT and AST between 2 groups(P0.05),however,adverse reactions in trial group were obviously less than those in control group.CONCLUSION:CG is effecacious and safe in the treatment of CHB and other damage of liver and its clinical efficacy is better than that of DG.
Key concepts: Glycyrrhizin, Medicine, Bilirubin, Adverse effect, Gastroenterology, Internal medicine, Chronic hepatitis, Therapeutic effect